SBC Medical Group
SBC
29 hedge funds and large institutions have $2.96M invested in SBC Medical Group in 2025 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
2,500% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 1
927% more capital invested
Capital invested by funds: $288K → $2.96M (+$2.67M)
625% more funds holding
Funds holding: 4 → 29 (+25)
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
0.53% more ownership
Funds ownership: 0.09% → 0.62% (+0.53%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$1.07M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$388K |
| 3 |
SS
SBI Securities
Tokyo,
Japan
|
+$149K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$139K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$116K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$233K |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$36.6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SCM
26
Sterling Capital Management
Charlotte,
North Carolina
| $668 | +$569 | +144 | New |
|
|
FFA
27
Farther Finance Advisors
San Francisco,
California
| $102 | +$87 | +22 | New |
|
28
Fidelity Investments
Boston,
Massachusetts
| $102 | +$87 | +22 | New |
|
|
TRCT
29
Tower Research Capital (TRC)
New York
| $65 | +$55 | +14 | New |
|
|
30
Marshall Wace
London,
United Kingdom
| – | -$36.6K | -11,485 | Closed |
|
SBC Hedge Fund Activity: Q2 2025 in Review
29 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in SBC Medical Group (SBC) for Q2 2025, worth a combined $2.96M — up 927% from $288K a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new SBC positions and 1 closed out — a net gain of 25 holders — while 2 added to existing stakes and 1 trimmed.
The largest buyer was BlackRock, opening a new position worth an estimated $1.07M. The largest seller was UBS Group, cutting an estimated $233K.
- 29 institutional investors held SBC Medical Group (SBC) as of Q2 2025, up from 4 in Q1 2025.
- Funds reported $2.96M of SBC Medical Group stock for Q2 2025, up 927% quarter-over-quarter.
- 26 funds opened new SBC Medical Group positions in Q2 2025 and 1 closed out, a net change of +25 holders.
- The largest SBC Medical Group buyer in Q2 2025 was BlackRock, an estimated $1.07M added.
- The largest SBC Medical Group seller in Q2 2025 was UBS Group, an estimated $233K sold.
Based on aggregated 13F filings for Q2 2025.